| For: | Wen JS, Pan ZW, Yao XD, Liu YQ, Zhu YD. Pristimerin ameliorates spasmolytic polypeptide-expressing metaplasia by modulating Cdkn1c (p57)-mediated glycolytic reprogramming. World J Gastroenterol 2026; 32(10): 113771 [PMID: 41809458 DOI: 10.3748/wjg.v32.i10.113771] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v32/i10/113771.htm |
| Number | Citing Articles |
| 1 |
Jun-Hao Han, Kong-Rui Lu, Min Zhang, Guo-Hua Gong. Pristimerin attenuates spasmolytic polypeptide-expressing metaplasia <i>via</i> p57 (<i>Cdkn1c</i>)-mediated glycolytic reprogramming: A metabolic avenue for gastric cancer prevention. World Journal of Gastroenterology 2026; 32(32): 118600 doi: 10.3748/wjg.118600
|
| 2 |
Siying Niu, Heyuan Sun, Zijian Wang, Qiuyu Jin, Zhiwen Sun, Dongyang Yu, Yang Zhang. Glycolytic reprogramming in precancerous lesions of gastric cancer progression: pathogenesis and therapeutic potential. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1885113
|